Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD.

STUDY OBJECTIVES The aim of this study was to examine the relationship between airway inflammation, nitrosative stress, heme-oxygenase expression, and acute severe exacerbations of COPD. DESIGN We measured heme oxygenase (HO)-1, inducible nitric oxide (NO) synthase expression and nitrotyrosine formation, as well as eosinophilic cationic protein, myeloperoxidase (MPO), interleukin (IL-8), and granulocyte macrophage-colony stimulating factor levels in induced sputum samples from 12 COPD patients (mean +/- SD; FEV1 40 +/- 14% predicted) at the onset of an acute severe exacerbation of COPD requiring hospital admission and 16 weeks after remission. RESULTS We demonstrated increased percentages (p = 0.001) and absolute numbers (p = 0.028) of total nitrotyrosine positive (+ve) inflammatory cells (ie, polymorphonuclear cells and macrophages), increased percentages (p = 0.04) and absolute numbers (p = 0.05) of total HO-1 +ve inflammatory cells, and increased MPO (p = 0.005) and IL-8 levels (p = 0.028) during severe exacerbation compared with the stable state. CONCLUSIONS Our results support the hypothesis of an involvement of inflammatory and nitrosative stress in severe COPD exacerbations. Future therapeutic strategies may aim at regulating inflammation and NO synthesis during COPD exacerbations.

[1]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[2]  R. Atmar,et al.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[3]  R. Stockley,et al.  Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD , 2001, Thorax.

[4]  J. Denburg,et al.  Use of induced sputum cell counts to investigate airway inflammation in asthma. , 1992, Thorax.

[5]  K. Roebuck.  Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). , 1999, International journal of molecular medicine.

[6]  K. Wright,et al.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[7]  P. Barnes,et al.  Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. , 2003, Chest.

[8]  Gibson,et al.  Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD) , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  A. Choi,et al.  Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. , 1999, The Journal of clinical investigation.

[10]  K. Shirato,et al.  Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. , 2000, American journal of respiratory and critical care medicine.

[11]  P. Barnes,et al.  Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.

[12]  Venge,et al.  Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  L. Fabbri,et al.  Airway eosinophilia and expression of interleukin‐5 protein in asthma and in exacerbations of chronic bronchitis , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  R. Stockley,et al.  Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis , 2002, Thorax.

[15]  D. Koller,et al.  Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity. , 1997, American journal of respiratory and critical care medicine.

[16]  S. Kawanishi,et al.  Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. , 2004, Biochemical and biophysical research communications.

[17]  N. Tzanakis,et al.  Induced sputum in the investigation of airway inflammation of COPD. , 2003, Respiratory medicine.

[18]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[19]  L. Fabbri,et al.  Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.

[20]  Mary Jane Thomassen,et al.  Regulation of No Synthesis Transcriptional and Post-translational Oxide (no) in Asthma: Evidence for Molecular Mechanisms of Increased Nitric , 2013 .

[21]  P. Barnes,et al.  Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease , 2003, Current allergy and asthma reports.

[22]  A. Choi,et al.  Heme oxygenase-1: the "emerging molecule" has arrived. , 2002, American journal of respiratory cell and molecular biology.

[23]  R. Djukanović,et al.  Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. , 1997, American journal of respiratory and critical care medicine.

[24]  C. Suschek,et al.  Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. , 2001, International immunopharmacology.

[25]  L. Fabbri,et al.  Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients , 2003, European Respiratory Journal.

[26]  W. MacNee,et al.  Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.

[27]  A. Agustí,et al.  Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[28]  R. Stockley,et al.  Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1–antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 , 2002, Thorax.

[29]  S. Uh,et al.  Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. , 1998, The European respiratory journal.

[30]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[31]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[32]  S. Matalon,et al.  Inhibition of human surfactant protein A function by oxidation intermediates of nitrite. , 2002, Free radical biology & medicine.

[33]  L. Fabbri,et al.  Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. , 2001, American journal of respiratory and critical care medicine.

[34]  J. Wedzicha.  Exacerbations Etiology and Pathophysiologic Mechanisms , 2002, Chest.

[35]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[36]  F. Hargreave,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1996, American journal of respiratory and critical care medicine.

[37]  K. Aben,et al.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[38]  W. MacNee,et al.  Prognostic significance of plasma D-dimer levels in patients with lung cancer. , 1997, Thorax.

[39]  R. Stockley,et al.  Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. , 2000, The European respiratory journal.